Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lots of patented products collecting dust.
Patents have zip to do with FDA approval.
They haven't filed the 510k.
The bio tests were pre-FDA 510k filing. It's right there in the RMSL timeline PR.
Pumpers don't like facts and would rather mislead other rookies into bad investments to lose money but there are folks who are objective and appreciate facts and rational information.
Total BS. Look at their PR drop history.
Even the most brain dead newbie understands that good news gets dropped for all to see in the morning and bad news is dropped after hours hoping to defray the impact.
Tom dropped this bomb and ran away in his typical fashion.
companies release PR 24/7 , I have tickers that dropped PR at 3 AM. Timing of this PR has no bearing on the content of it .
Red herring to keep shareholders at bay. The only thing this company can do is file paperwork. They can't make the design pass the muster with the FDA.
Total sham and anyone who is trying to push this as good news is doing damage to gullible rookie investors.
Sure...hence the late night PR bomb drop.
That is a confirmation the 510k was submitted. ETC is making sure the submission is accepted and approved. They will take over managing the process. Stop the false narrative.
Years and another RS before 510k approval.
3rd party straw man to keep shareholder's off Tom's back while he dilutes the company into oblivion.
What kind of a real company can't get their own product approved by the FDA after six years and then needs to bring in someone else to do the job. What is this company supposed to do? Re-design the product?
Total disaster.
InvestmentLongGone after epic 510k approval wait.
Confirmation the 510k hasn't been filed.
https://www.newmediawire.com/news/remsleep-510k-5271376
REMSLEEP HOLDINGS, INC. ENGAGES NEW REGULATORY AGENCY
Tampa, FL, June 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC:RMSL) (the "Company") announces the company has engaged Empirical Technologies Corp to complete its 510K process. Remsleep has become frustrated with the progress of its 510K submission. Partnering with ETC will ensure the Remsleep 510K submission will be streamlined and put the company's 510K submission on the right track. Remsleep plans to engage ETC with all future regulatory needs. 510K submissions through ETC have record of approval 20% to 40% faster than the industry average. ETC has a 100% success rate with filing 510K's, which gives the company confidence with the submission.
Remsleep received patent approval of its utility patent application April 2021.
The company is poised to launch marketing program as soon as 510k clearance is complete. The company continues to work on new product and expects to release future product with far greater ease and timely manner.
You gave up on a goldmine. Mark my words. ??
This stock is going to zero. I owned 1.6 million shares for way too long and luckily I was able to get out with a profit. Treat this as a service announcement. I don't care if you disagree with me because I know what I know and mark my word.
Sell your shares.
Would be insider trading if we knew now, wouldn’t it? ??
Many of us are holding big. ??
A great number of us have been accumulating for the near future FDA decision on DeltaWave. ??
Yes certainly seems that way, some decent buys today.
Welcome home! Tom's waiting with the hot cocoa!
Frequent 510k updates Tom promised?
https://www.globenewswire.com/news-release/2020/11/19/2130417/0/en/REMSleep-Holdings-Time-Line-Update.html
This is how newbie accounts get killed.
Debt conversion (convertible notes) is the very definition of dilution. OS increase is the black and white evidence of dilution.
Can't be too lazy to learn about convertible notes and the dilutive effect they have on your investment or you will pay for it eventually.
Is the float locked yet????
A/S raise just filed end of November!
It means they don't have to file to raise the AS, Still 526M OS not 2.8B
RMSL
Share Structure
Market Cap 11,313,935 05/21/2021
Authorized Shares 3,000,000,000 05/07/2021
Outstanding Shares 526,229,517 05/07/2021
Restricted 54,929,546 05/07/2021
Unrestricted 471,299,971 05/07/2021
Held at DTC Not Available
Tom's a regular Willy Wonka!
3 Billion A/S means everlasting shares!
Say what you want about the company's inactivity,but this one's been under accumulation for weeks.
They are showing $159k cash in hand on financials if that helps.
Tom resting comfortably on his MyPermaBull pillow.
No pressure Tom. Take your time. All good here.
Fresh herd of PermaBulls got your back.
This or that? Try reading the financials it might take the mystery out of it for you. This is their quarterly house money to stay afloat.
Maybe you could take a look at the chart from the reverse split in 2017 to see what happens to your investment with nonstop dilution.
Maybe they spent the $150k on this or that? Maybe they haven't burnt through the cash? Maybe they need it to cover net 90 on millions of units? Maybe they will hire a PR person to update shareholders every 5 minutes on twitter so people don't have to day dream about what they are doing all day? People would be less stressed, if they knew not to invest rent money. Not an expert.
Excellent philosophy.
Tight chart appears ready for a big move.Hopefully North.Lotsa accumulation over the past few weeks.
How short are you ? tia
They are burning through this amount of cash each quarter just to stay afloat.
The money they are borrowing from the note holders isn't dollar for dollar. The note holders are converting their shares at drastically reduced rates which dilutes the company rapidly and makes your piece of the pie that much slimmer.
Every time the FDA requires Tom to make modifications to the device there are large engineering, tooling, and manufacturing costs. He's had a lot of issues with the molds for several years. No way to look on the internet to compare FDA costs just like there's no way to compare FDA clearance timelines. No one would have predicted the DeltaWave would not be cleared six years ago if they used internet FDA clearance comparables.
Tom's already put it out there that there is going to be a steeper regulatory climb which equates to time and money.
It's going to require a lot more cash because it's going to require a lot more time. The longer it takes for the FDA clearance the closer to the fully diluting the 3 billion in authorized shares which won't leave much meat on the bone if you are long.
In one of your older comments, i remember you saying.....and this isn't verbatim as id have to go find it....but something along the lines of "if they truly did submit a 510k, that would require allot of cash that they dont have". So, i don't necessarily think this is a bad thing. The total for those loans are 151k. The average cost to submit a 510k with clinical data is something like $120k isn't it? (google researching) Not saying this is exactly how it was/is used, as i have no idea, but as i said....i don't exactly see additional funding as a bad thing. Especially knowing the potential success of their new product.
10Q out. $150k in new notes added.
Granite Global $31k
Granite Global $36k
Power Up $84k
30% of the company diluted in one month.
rmsl turning out to be dogchit.
Posts are chock full of DD detailing the "indications" for why the 510k hasn't been filed but I imagine it's a lost cause if one can't be bothered to read the paragraph bio of the CEO.
Followers
|
309
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |